Chemoinformaics analysis of 2,6,8-Trimethyldecane
| Molecular Weight | 184.367 | nRot | 7 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 3 |
| Exact Molecular Weight | 184.219 | nRing | 0 |
| Solubility: LogS | -4.311 | nHRing | 0 |
| Solubility: LogP | 5.021 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 40.3802 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.278 |
| Synth | 2.617 |
| Natural Product Likeliness | 1.783 |
| NR-PPAR-gamma | 0.082 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.352 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.67 |
| MDCK | 0.0000178 |
| BBB | 0.994 |
| PPB | 0.872877 |
| VDSS | 2.448 |
| FU | 0.0588708 |
| CYP1A2-inh | 0.774 |
| CYP1A2-sub | 0.507 |
| CYP2c19-inh | 0.483 |
| CYP2c19-sub | 0.567 |
| CYP2c9-inh | 0.253 |
| CYP2c9-sub | 0.915 |
| CYP2d6-inh | 0.21 |
| CYP2d6-sub | 0.766 |
| CYP3a4-inh | 0.46 |
| CYP3a4-sub | 0.15 |
| CL | 2.875 |
| T12 | 0.376 |
| hERG | 0.121 |
| Ames | 0.759 |
| ROA | 0.628 |
| SkinSen | 0.989 |
| Carcinogencity | 0.64 |
| EI | 0.978 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.677 |
| Antiviral | Yes |
| Prediction | 0.571356 |